[SCHEDULE 13D] Corvex, Inc. Major Shareholder Acquisition (>5%)

Rhea-AI Filing Summary

Corvex, Inc. Co-Chief Executive Officer John Crystal III reports beneficial ownership of 4,071,809 shares of Common Stock, representing 14.8% of the outstanding class. His holdings include shares owned directly and through a Roth IRA trust for which he serves as trustee.

These shares were largely received between March and July 2026 as consideration for Corvex, Inc.’s acquisition of Corvex Legacy Holdings, Inc., reflecting his prior ownership and compensation there. He also holds additional unvested restricted stock units and unexercisable stock options that are not counted in his current beneficial ownership.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/08/2026 - 08:14 PM Accepted by SEC EDGAR 07/08/2026 - 08:13 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Corvex, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

62459M305

(CUSIP Number)

John Crystal III
3401 North Fairfax Drive, Suite 3230
Arlington, VA, 22226
(866) 438-4787

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

07/01/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 62459M305

1

Name of reporting person

John Crystal III

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 4,071,809.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 4,071,809.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

4,071,809.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

14.8 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

(1) Consists of (i) 3,360,488 shares of Common Stock held directly by Mr. John Crystal III (the "Reporting Person") and (ii) 711,321 shares of Common Stock held by the John Adler Crystal III Roth IRA (the "Trust"). The Reporting Person is the trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. Such amount excludes an additional 3,054,235 shares of Common Stock underlying restricted stock units that will not vest in the next 60 days and 2,902,143 shares of Common Stock underlying stock options that are not exercisable in the next 60 days. (2) Based on the 27,635,745 shares of Common Stock outstanding as of July 7, 2026.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock
(b)	Name of Issuer: Corvex, Inc.
(c)	Address of Issuer's Principal Executive Offices: 3401 North Fairfax Drive, Suite 3230, Arlington, VIRGINIA , 22226.
Item 1 Comment: This Schedule 13D relates to the shares of common stock, par value $0.0001 (the "Common Stock") of Corvex, Inc. (the "Issuer"). The principal executive offices of the Issuer are located at 3401 North Fairfax Drive, Suite 3230, Arlington, Virginia, 22226.
Item 2.	Identity and Background
(a)	John Crystal III (the "Reporting Person").
(b)	The business address for the Reporting Person is: 3401 North Fairfax Drive, Suite 3230, Arlington, Virginia, 22226.
(c)	Mr. Crystal serves as Co-Chief Executive Officer of the Issuer and a member of the Issuer's Board of Directors.
(d)	During the last five years, the Reporting Person has not been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	During the last five years, the Reporting Person was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	The Reporting Person is a citizen of the United States.
Item 3.	Source and Amount of Funds or Other Consideration
	The Reporting Person received an aggregate of 4,071,809 shares of Common Stock between March and July 2026 as consideration from the Issuer's acquisition of Corvex Legacy Holdings, Inc. (formerly Corvex, Inc.) ("Corvex OpCo"). The Reporting Person's ownership of Corvex OpCo securities was funded from his personal funds or received for services as Co-Chief Executive Officer of Corvex OpCo. All other shares of Common Stock and derivative securities described in Item 5 below have been issued to the Reporting Person in connection with his services to the Issuer as Co-Chief Executive Officer and member of the Board of Directors.
Item 4.	Purpose of Transaction
	Mr. Crystal serves as Co-Chief Executive Officer of the Issuer and a member of the Issuer's Board of Directors. In such capacity, Mr. Crystal may engage in communications with the Board of Directors of the Issuer, members of management of the Issuer, other shareholders of the Issuer, financial and legal advisers and other parties regarding the Issuer, including but not limited to its operations, governance and control. In addition, in his capacity as Co-Chief Executive Officer of the Board, Mr. Crystal may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of the instructions to Item 4 of Schedule 13D. Except as set forth herein, the Reporting Person does not have any plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of Schedule 13D. The Reporting Person may, at any time and from time to time, review or reconsider his positions and/or change his purpose and/or formulate plans or proposals with respect thereto.
Item 5.	Interest in Securities of the Issuer
(a)	The Reporting Person beneficially own an aggregate of 4,071,809 shares of the Issuer's Common Stock. Such amount represents 14.8% of the outstanding shares of Common Stock based on the 27,635,745 shares of Common Stock outstanding as of July 7, 2026.
(b)	Mr. Crystal has the sole power to vote or direct the vote of 4,071,809 shares of Common Stock; has the shared power to vote or direct the vote of no shares of Common Stock; has the sole power to dispose or direct the disposition of 4,071,809 shares of Common Stock; and has the shared power to dispose or direct the disposition of no shares of Common Stock. Such shares consist of (i) 3,360,488 shares of Common Stock held directly by Mr. Crystal and (ii)711,321 shares of Common Stock held by the Trust. The Reporting Person is the trustee of the Trust and has sole voting and dispositive power over the Common Stock held by the Trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. Such amount excludes an additional 3,054,235 shares of Common Stock underlying restricted stock units that will not vest in the next 60 days and 2,902,143 shares of Common Stock underlying stock options that are not exercisable in the next 60 days.
(c)	On March 19, 2026, the Reporting Person received various shares of the Issuer's preferred stock representing an aggregate of 4,071,809 shares of Common Stock as consideration for the Issuer's acquisition of Corvex OpCo. Pursuant to the conversion of such shares of preferred stock, 18,132 shares of Common Stock were received on March 31, 2026 and an additional 4,053,677 shares of Common Stock were received on July 7, 2026. The Reporting Person's ownership of Corvex OpCo securities was funded from his personal funds and as compensation for his services as Co-Chief Executive Officer of Corvex OpCo.
(d)	None.
(e)	Not applicable.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	There are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person and any other person with respect to any securities of the Issuer.
Item 7.	Material to be Filed as Exhibits.
	1. Power of Attorney, dated July 7, 2026.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

John Crystal III

Signature:	/s/ Mark Busch
Name/Title:	Attorney-in-Fact
Date:	07/08/2026

Comments accompanying signature:

This Schedule 13D was executed by Mark Busch as Attorney-in-Fact for John Crystal III pursuant to the Power of Attorney granted thereby, a copy of which is attached as Exhibit 1.